Veeva MedTech Clinical Trials Report Signals Significant Opportunity to Improve Data Delivery and Quality
Research reveals most medtech companies (
The report highlights key areas for improvement and progress made in medtech clinical research, including:
- Disconnected systems remain a crucial issue: More than half of respondents (
61% ) experience challenges with fragmented clinical systems because of cross-system integration, data management, reporting, and usability. Managing studies on siloed systems can lead to manual errors, duplicate data, and missing files. - A clear strategy is needed for post-market clinical follow-up (PMCF): There was no single method for PMCF used by most respondents, with top approaches reported as real-world evidence (
21% ), literature search (20% ), and comparison studies (20% ). Without a standard method to meet PMCF, organizations can benefit from developing an end-to-end process that spans clinical, medical, regulatory, quality, and marketing for continuous data gathering throughout the product lifecycle. - Shift to digital clinical systems accelerating this year: Nearly half (
45% ) say shifting to digital clinical systems is a top priority over the next 12 months. Establishing a digital and connected technology foundation will make it easier for study stakeholders to work together, increasing trial efficiency, accelerating data delivery, and improving the experience for sites.
"The medtech industry has a significant opportunity to modernize clinical systems and processes for faster access to trial data," said
The Veeva MedTech Clinical Benchmark study examined how organizations—ranging from emerging to large device and diagnostics companies—manage clinical processes, study site collaboration, and trial data to ensure compliance and speed. This report includes insights from more than 135 clinical medtech professionals worldwide, outlining current challenges and near-term priorities associated with clinical trial conduct. See the full report, which investigates how medtech companies are managing clinical operations, outsourcing, post-market clinical follow-up, and modernization.
About
Contact:
925-226-8821
deivis.mercado@veeva.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/veeva-medtech-clinical-trials-report-signals-significant-opportunity-to-improve-data-delivery-and-quality-301801426.html
SOURCE